tirzepatide surmount 3 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Diabetes Dialogue: SURMOUNT-3 and -4

We received comments concerning participant burden that may be introduced by ASM

Bermans Program Different

The specific dose depends on the patients individual presentation, tolerability, and broader supplement protocol

It is not an exhaustive protocol and Health Professionals are advised that adequate professional supervision is accessed to ensure that Duty of Care obligations with respect to safe administration of medicines is met for each consumer.

Figure 1 Characteristics of included studies To ensure methodological clarity and appropriately weight the evidence, the included literature is organized into four distinct categories: completed head-to-head trials, contextual cardiovascular outcome trials, real-world observational studies, and ongoing (non-analytical) studies